XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73−0.05 (-2.81%)
Close on Nov 18, 2026Market cap $52.74MP/E –Yield –
XBiotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
XBiotech's net income for the twelve months ending Jun 30, 2026 was -$45.13M. For fiscal 2025 it was -$45.54M. The highest annual figure on record is $668.63M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$45.54M | – |
| FY2024 | Dec 31, 2024 | -$38.53M | – |
| FY2023 | Dec 31, 2023 | -$24.56M | – |
| FY2022 | Dec 31, 2022 | -$32.90M | – |
| FY2021 | Dec 31, 2021 | -$17.41M | – |
| FY2020 | Dec 31, 2020 | -$11.22M | -101.7% |
| FY2019 | Dec 31, 2019 | $668.63M | – |
| FY2018 | Dec 31, 2018 | -$21.14M | – |
| FY2017 | Dec 31, 2017 | -$33.15M | – |
| FY2016 | Dec 31, 2016 | -$52.76M | – |
| FY2015 | Dec 31, 2015 | -$37.48M | – |
| FY2014 | Dec 31, 2014 | -$21.72M | – |
| FY2013 | Dec 31, 2013 | -$9.93M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.73M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$26.89M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.01M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.76M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.01M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.00M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.64M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.36M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.82M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.20M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.66M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.40M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.47M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.26M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.12M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.57M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.84M | -100.3% |
| Q3 FY2020 | Sep 30, 2020 | -$2.53M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.84M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $686.50M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.15M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.85M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.86M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.11M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.05M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.91M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.07M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.25M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.21M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.13M | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$16.40M | – |
| Q3 FY2016 | Sep 30, 2016 | -$12.48M | – |
See a number that looks wrong?